Yumanity Therapeutics Overview
- Founded
- 2014
- Status
- Public
- Employees
- 41
- Stock Symbol
- YMTX
- Investments
- 1
- Share Price
- $19.90
- (As of Friday Closing)
Yumanity Therapeutics General Information
Description
Yumanity Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerative diseases. The company's advanced product candidate, YTX-7739, which is in phase 1 clinical development for Parkinson's disease.
Contact Information
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Biotechnology
Stock Exchange
NAS
Primary Office
- 40 Guest Street
- Suite 4410
- Boston, MA 02135
- United States
+1 (617) 000-0000
Yumanity Therapeutics Timeline
Yumanity Therapeutics Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $19.90 | $20.22 | $16.27 - $23.47 | $201M | 10.1M | 80.6K |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Yumanity Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
This information is available in the PitchBook Platform. To explore Yumanity Therapeutics‘s full profile, request access.
Request a free trialYumanity Therapeutics Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Yumanity Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery and development
Drug Discovery
Boston, MA
41
As of 2020
00000
000000000000
00000
000000 0
dipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim
0000 000000000
Toronto, Canada
0
As of 0000
000.00
000000000
000.00
00000000
nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt m
0000 000000000
Cambridge, MA
00
As of 0000
000.00
0000000000 0
000.00
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialYumanity Therapeutics Competitors (26)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| ProMIS Neurosciences | Corporation | Toronto, Canada | 0 | 000.00 | 000000000 | 000.00 |
| 000000000 00000000 | Venture Capital-Backed | Cambridge, MA | 00 | 000.00 | 0000000000 0 | 000.00 |
| 0000000 | Private Equity-Backed | San Diego, CA | 000 | 00000 | 000000000 - | 00000 |
| 0000000 0000000000 | Venture Capital-Backed | Cambridge, MA | 0000 | 00000000000 | 0000 | |
| 0000 | Venture Capital-Backed | San Diego, CA | 00 | 00.000 | 0000000000 0 |
Yumanity Therapeutics Executive Team (13)
Yumanity Therapeutics Board Members (13)
| Name | Representing | Role | Since |
|---|---|---|---|
| Cecil Pickett Ph.D | Yumanity Therapeutics | Board Member | 000 0000 |
| David Arkowitz | Self | Board Member | 000 0000 |
| Jeffery Kelly Ph.D | Self | Board Member | 000 0000 |
| Joel Marcus JD | Alexandria Venture Investments | Board Member | 000 0000 |
| John Cox | Self | Board Member | 000 0000 |
Yumanity Therapeutics Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialYumanity Therapeutics Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
This information is available in the PitchBook Platform. To explore Yumanity Therapeutics‘s full profile, request access.
Request a free trialYumanity Therapeutics Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000000000 00000 | 22-Dec-2020 | 000000000000000000 | Drug Discovery | 0000000 000000 00.0 |